(Information sent by the signatory company)
- Veeva Pulse shows HCP access in Europe averaging 52% with the highest growth in content-based digital engagement worldwide
Access is selective as most HCPs meet with three or fewer companies
BARCELONA, Spain, Nov. 29, 2022/PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released the first look at healthcare professional (HCP) access in key European markets from Veeva Pulse's Veeva Pulse Field Trends Report, the largest global industry benchmark of its kind on HCP engagement. Data shows that access for healthcare professionals in Europe now averages 52% across all countries, driven by the increasing use of video conferencing and content to complement in-person visits.
These new findings underscore the impact of digital, as a third of accessible HCPs now interact via video alongside in-person, and the addition of video is shown to increase the length and frequency of meetings for more engagement. significant. This combination of reach, channel preference, and effectiveness is even more critical, as 65% of accessible HCPs limit participation to three companies or fewer.
The latest data from Veeva Pulse shows that the combination of video and in-person meetings maximizes access to the field:
"The Veeva Pulse Field Trends report offers the broadest view ever into HCP access and channel effectiveness across the industry so teams can definitively compare what actions they can take to strengthen engagement and drive better results," Aaron explained. Bean, Veeva's vice president of business consulting, Europe. "Seeing how access has changed and HCPs are very selective about meetings, the most successful companies are optimizing digital channels to increase reach and deliver impactful, relevant content to maximize the quality of each engagement."
About the Veeva Pulse Field Trends Report
Analyzing more than 600 million HCP interactions and activities annually from more than 80% of commercial biopharmaceutical field teams worldwide, it is the largest industry benchmark of its kind on HCP engagement. The analysis compiles real-time transactional data recorded in Veeva CRM globally and from European markets, including the UK, Italy, Germany, France and Spain. Indexed by Veeva on a quarterly basis, the data will help companies effectively and accurately benchmark performance to set the right, actionable goals for continued growth and impact.
Analyzing more than 600 million HCP interactions and activities annually from more than 80% of biopharmaceutical field business teams worldwide, the Veeva Pulse Field Trends Report is the benchmark for Veeva Pulse Field Trends. largest industry of its kind related to HCP engagement. The analysis compiles real-time transactional data recorded in Veeva CRM globally and from European markets, including the UK, Italy, Germany, France and Spain. Indexed by Veeva on a quarterly basis, the data will help companies effectively and accurately benchmark performance to set the right, actionable goals for continued growth and impact.
Additional Information
To download a copy of the Veeva Pulse Field Trends Report, visit: veeva.com/eu/FieldTrends Learn more about Veeva Business Consulting: veeva.com/eu/BusinessConsulting Contact Veeva on LinkedIn: linkedin.com/company/veeva- systems
About Veeva Systems
Veeva is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechnologies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
Photo - https://mma.prnewswire.com/media/1956750/Europe_Field_Activity_by_Country.jpg
Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg
View original content: https://www.prnewswire.com/news-releases/veeva-pulse-muestra-que-el-acceso-de-hcp-en-europa-tiene-un-promedio-del-52-301689160.html
